Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Opko Health Inc (OPK)
NASDAQ:OPK
Holding OPK?
Track your performance easily
OPK Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.85 - $1.75
Previous Close$1.62
Volume3.49M
Average Volume (3M)3.25M
Market Cap
$1.13B
Enterprise Value$1.35B
Total Cash (Recent Filing)$40.58M
Total Debt (Recent Filing)$259.49M
Price to Earnings (P/E)―
Beta1.22
Next Earnings
Nov 05, 2024EPS Estimate
-$0.09Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.33
Shares Outstanding697,376,055
10 Day Avg. Volume3,330,745
30 Day Avg. Volume3,245,383
Standard Deviation0.21
R-Squared0.16
Alpha-0.00112
Financial Highlights & Ratios
Price to Book (P/B)0.80
Price to Sales (P/S)1.58
Price to Cash Flow (P/CF)-10.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.88
Enterprise Value/Gross Profit4.24
Enterprise Value/Ebitda-10.65
Forecast
1Y Price Target
$2.75Price Target Upside72.96% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Opko Health News
PremiumCompany Announcements
Opko Health Subsidiary Restructures with Strategic Sale and Debt Settlement
Bulls Say, Bears Say
Bulls Say
Clinical TrialsModeX Phase 1 solid tumor trial is set to begin patient enrollment, marking a significant step forward in their clinical pipeline.
DivestmentOPKO's agreement to divest around $100 million in annual BRL revenue to Labcorp will streamline operations and focus on core business activities.
RevenueThe company is anticipated to receive $237.5M from the Labcorp transaction, significantly boosting its financial position.
Bears Say
EarningsConsolidated total revenues were $173.7M, representing a 27% YoY decline and missing analyst projection of $180.0M.
Financial PerformanceOPKO’s first quarter financial results fell short both in terms of top-line performance and EPS relative to analyst modeling as well as consensus.
RevenueNGENLA revenue came in lighter than expected by both analysts and the company.
---
Ownership Overview
64.66% Insiders
6.98% Mutual Funds
16.82% Other Institutional Investors
11.54% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
OPK FAQ
What was Opko Health Inc’s price range in the past 12 months?
Opko Health Inc lowest stock price was $0.85 and its highest was $1.75 in the past 12 months.
What is Opko Health Inc’s market cap?
Currently, no data Available
When is Opko Health Inc’s upcoming earnings report date?
Opko Health Inc’s upcoming earnings report date is Nov 05, 2024 which is in 46 days.
How were Opko Health Inc’s earnings last quarter?
Opko Health Inc released its earnings results on Aug 07, 2024. The company reported -$0.01 earnings per share for the quarter, beating the consensus estimate of -$0.095 by $0.085.
Is Opko Health Inc overvalued?
According to Wall Street analysts Opko Health Inc’s price is currently Undervalued.
Does Opko Health Inc pay dividends?
Opko Health Inc does not currently pay dividends.
What is Opko Health Inc’s EPS estimate?
Opko Health Inc’s EPS estimate is -$0.09.
How many shares outstanding does Opko Health Inc have?
Opko Health Inc has 697,376,040 shares outstanding.
What happened to Opko Health Inc’s price movement after its last earnings report?
Opko Health Inc reported an EPS of -$0.01 in its last earnings report, beating expectations of -$0.095. Following the earnings report the stock price went up 11.719%.
Which hedge fund is a major shareholder of Opko Health Inc?
Among the largest hedge funds holding Opko Health Inc’s share is Gamco Investors, Inc. ET AL. It holds Opko Health Inc’s shares valued at 219K.
---
Opko Health Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$2.75 (72.96% Upside)
$2.75 (72.96% Upside)
Blogger Sentiment
Bullish
OPK Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 24.9K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.7%
Last 30 Days ▼ 2.3%
Last 30 Days ▼ 2.3%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
0.00%
12-Months-Change
Fundamentals
Return on Equity
-16.59%
Trailing 12-Months
Asset Growth
-8.29%
Trailing 12-Months
Company Description
Opko Health Inc
OPKO Health, Inc. engages in the provision of healthcare services. It operates through the Diagnostics and Pharmaceuticals segments. The Diagnostics segment comprises clinical laboratory operations which acquired through the Bio-Reference and point-of-care operations. The Pharmaceuticals segment includes the pharmaceutical operations acquired in Chile, Mexico, Ireland, Israel, and Spain; and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.
---
OPK Earnings Call
Q2 2024
0:00 / 0:00
---
OPK Stock 12 Month Forecast
Average Price Target
$2.75
▲(72.96% Upside)
Technical Analysis
Best Analysts Covering OPK
1 Year
1 Year Success Rate
15/36 ratings generated profit
1 Year Average Return
+12.29%
reiterated a buy rating last month
Copying Michael Petusky's trades and holding each position for 1 Year would result in 41.67% of your transactions generating a profit, with an average return of +12.29% per trade.
---